-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Public Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSInstitute Report
Trends in Vaccine Administration in the United States
Jan 13, 2023
The COVID-19 pandemic led to an increased role of pharmacies in the overall immunization process as they served as key sites of administration of the COVID-19 vaccines. The Public Readiness and Emergency Preparedness (PREP) Act also expanded the role of pharmacists and interns in vaccine administration overall over the course of the pandemic.
This report aims to understand the role of pharmacists in the immunization process by analyzing whether a person received a vaccine at a pharmacy or a medical location for several vaccines between 2018 and 2022 (through the second quarter). The report also analyzes whether there are differences in the site of vaccine administration by gender, income, or race. This analysis provides an understanding of the important role that pharmacies are playing across vaccines and especially for adult vaccines.
Key Findings
Exhibit 1: Number of claims/100,000 eligible persons and % share of adult* vaccines in pharmacy vs. non-pharmacy medical settings
- Overall, across all vaccines for adults in-scope, a large majority of the administration took place at the pharmacy level compared to a non-pharmacy medical setting (Excluding temporary, government public health sites and sites where a claim would not be generated)
- 2020 and 2021 saw a steep increase in vaccine administration at pharmacies due to the COVID-19 vaccine
Exhibit 2: Number of claims/100,000 eligible persons and % share of COVID-19 vaccines for adults in pharmacy vs. non-pharmacy medical settings
- Many people received COVID-19 vaccines at pharmacies, irrespective of gender, race/ethnicity, or income
- More than 90% of COVID-19 vaccinations provided through either medical centers or pharmacies were delivered at pharmacies (Excluding temporary, government public health sites and sites where a claim would not be generated)
- The Shingles vaccine also saw a similar trend, with a large majority of administration taking place at the pharmacy level across all of the years analyzed
Exhibit 4: Number of claims/100,000 eligible persons and % share of flu vaccines for adults in pharmacy vs. non-pharmacy medical settings
- Pharmacies serve as an important part of the overall flu vaccination process, with 60-70% of vaccinations during flu season (third and fourth quarters) taking place at pharmacies
- The trend in flu vaccine administration at pharmacies also indicates a 30-40% increase in claims for flu vaccines between 2018/19 and 2020
Exhibit 5: Number of claims/100,000 eligible persons and % share of Pneumococcal vaccines for adults in pharmacy vs. non-pharmacy medical settings
- A large proportion of Pneumococcal vaccine administration also took place at pharmacies. In the third and fourth quarters of any given year, around 40-50% of the administration occurs in a pharmacy setting
- The overall number of claims also consistently increases in these quarters compared to the first and second quarters
- These trends may be associated with the flu season as people may be interacting more with pharmacists for the flu vaccine and may be informed of the Pneumococcal vaccine
- These vaccine administration trends generally hold irrespective of gender, race and income. For some vaccines, Hispanic and Asian American populations see a larger proportion of administration at pharmacies compared to other racial/ethnic categories
Institute Reports
Trends in Global Adult Vaccination
This research brief from the IQVIA Institute – Trends in Global Adult Vaccination: Impact of COVID-19 – aims to provide a baseline of adult vaccination trends and missed vaccination doses during the COVID-19 pandemic while assessing variations by countries and regions.